References
- Mehta M , SatijaS, PaudelKRet al. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: current status and future perspectives. Nanomedicine31, 102303 (2021).
- Mehta M , DhanjalDS, PaudelKRet al. Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update. Inflammopharmacology28(4), 795–817 (2020).
- Viegi G , MaioS, FasolaS, BaldacciS. Global burden of chronic respiratory diseases. J. Aerosol Med. Pulm. Drug Deliv.33(4), 171–177 (2020).
- Campisi J , d’Addadi Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol.8(9), 729–740 (2007).
- Barnes PJ , BakerJ, DonnellyLE. Cellular senescence as a mechanism and target in chronic lung diseases. Am. J. Respir. Crit. Care Med.200(5), 556–564 (2019).
- Baker JR , VuppusettyC, ColleyTet al. Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells. Sci. Rep.6, 35871 (2016).
- Mohamed A , KundaNK, RossK, HutcheonGA, SaleemIY. Polymeric nanoparticles for the delivery of miRNA to treat chronic obstructive pulmonary disease (COPD). Eur. J. Pharm. Biopharm.136, 1–8 (2019).
- Tsuji T , AoshibaK, NagaiA. Alveolar cell senescence in patients with pulmonary emphysema. Am. J. Respir. Crit. Care Med.174(8), 886–893 (2006).
- Prasad M , LambeUP, BrarBet al. Nanotherapeutics: an insight into healthcare and multi-dimensional applications in medical sector of the modern world. Biomed. Pharmacother.97, 1521–1537 (2018).
- Kim EC , KimJR. Senotherapeutics: emerging strategy for healthy aging and age-related disease. BMB Rep.52(1), 47–55 (2019).
- Mullard A . Anti-ageing pipeline starts to mature. Nat. Rev. Drug Discov.17(9), 609–612 (2018).
- Dua K , MalylaV, SinghviGet al. Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: an emerging need for novel drug delivery systems. Chem. Biol. Interact.299, 168–178 (2019).
- Ng PQ , LingLSC, ChellianJet al. Applications of nanocarriers as drug delivery vehicles for active phytoconstituents. Curr. Pharm. Des.26(36), 4580–4590 (2020).
- Agostini A , MondragónL, BernardosAet al. Targeted cargo delivery in senescent cells using capped mesoporous silica nanoparticles. Angew. Chem. Int. Ed. Engl.51(42), 10556–10560 (2012).
- Zhong Q , MerkelOM, ReinekeJJ, da RochaSRP. Effect of the route of administration and PEGylation of poly(amidoamine) dendrimers on their systemic and lung cellular biodistribution. Mol. Pharm.13(6), 1866–1878 (2016).
- Lewinska A , Adamczyk-GrochalaJ, BloniarzDet al. AMPK-mediated senolytic and senostatic activity of quercetin surface functionalized Fe3O4 nanoparticles during oxidant-induced senescence in human fibroblasts. Redox Biol.28, 101337 (2020).
- Mohamed A , PekozAY, RossK, HutcheonGA, SaleemIY. Pulmonary delivery of nanocomposite microparticles (NCMPs) incorporating miR-146a for treatment of COPD. Int. J. Pharm.569, 118524 (2019).
- Amore E , FerraroM, MancaMLet al. Mucoadhesive solid lipid microparticles for controlled release of a corticosteroid in the chronic obstructive pulmonary disease treatment. Nanomedicine (Lond.)12(19), 2287–2302 (2017).
- Duan WX , HeMD, MaoLet al. NiO nanoparticles induce apoptosis through repressing SIRT1 in human bronchial epithelial cells. Toxicol. Appl. Pharmacol.286(2), 80–91 (2015).
- Bhushan B , GopinathP. Antioxidant nanozyme: a facile synthesis and evaluation of the reactive oxygen species scavenging potential of nanoceria encapsulated albumin nanoparticles. J. Mater. Chem. B3(24), 4843–4852 (2015).